#generic-drugs

[ follow ]
#patents

Supreme Court Preview: Will "Skinny Labels" Get a Weight Check?

The Supreme Court will address the issue of generic drug manufacturers and potential patent infringement in the Hikma v. Amarin case.

C4IP Urges Senate Judiciary to Ignore Common Myths About Drug Patents

'Evergreening' and 'patent thicketing' aren't a barrier to cheaper generics.

Supreme Court Preview: Will "Skinny Labels" Get a Weight Check?

The Supreme Court will address the issue of generic drug manufacturers and potential patent infringement in the Hikma v. Amarin case.

C4IP Urges Senate Judiciary to Ignore Common Myths About Drug Patents

'Evergreening' and 'patent thicketing' aren't a barrier to cheaper generics.
morepatents
#patent-law

Senate Committee Advances PREVAIL Act

The PREVAIL Act is set to change PTAB procedures, impacting patent challenges and potentially affecting generic drug pricing.
New provisions aim to balance patent protection with access to affordable medications.

Teva v. Amneal: Orange Book Listing Requirements Under Scrutiny

The Federal Circuit's ruling may reshape patent listing practices under Hatch-Waxman, influencing generic drug market access.
The case challenges the suitability of listing device patents in the Orange Book regarding patent claims.
The ruling could define how device patents relate to broader patent strategies for pharmaceuticals.

Senate Committee Advances PREVAIL Act

The PREVAIL Act is set to change PTAB procedures, impacting patent challenges and potentially affecting generic drug pricing.
New provisions aim to balance patent protection with access to affordable medications.

Teva v. Amneal: Orange Book Listing Requirements Under Scrutiny

The Federal Circuit's ruling may reshape patent listing practices under Hatch-Waxman, influencing generic drug market access.
The case challenges the suitability of listing device patents in the Orange Book regarding patent claims.
The ruling could define how device patents relate to broader patent strategies for pharmaceuticals.
morepatent-law
#drug-shortages

Why do hospitals keep running out of generic drugs?

Hospitals face persistent shortages of common generic drugs due to complex market issues affecting production and distribution.

US drug shortages reach record high with 323 meds now in short supply

Drug shortages in the US have hit a record high in 2023, with concerns around generic sterile injectables and ADHD therapies.

Why do hospitals keep running out of generic drugs?

Hospitals face persistent shortages of common generic drugs due to complex market issues affecting production and distribution.

US drug shortages reach record high with 323 meds now in short supply

Drug shortages in the US have hit a record high in 2023, with concerns around generic sterile injectables and ADHD therapies.
moredrug-shortages

Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries

Gilead aims to broaden access to lenacapavir through generic production in low-income countries but excludes middle-income nations, highlighting healthcare disparities.

FDA hasn't inspected nearly 2,000 drug plants since before COVID pandemic

FDA inspections of pharmaceutical firms remain significantly behind pre-pandemic levels, raising contamination risks in critical medications.

Amarin Seeks En Banc Review in Skinny Label Inducement

Hikma's petition challenges the Federal Circuit's skinny label jurisprudence, with implications for patent protections in the pharmaceutical sector.

Call Off Chicken Little: The Sky is Not Falling for Skinny Labeling After GSK v. Teva

Generic companies using skinny labeling should not receive preferential treatment for inducement purposes, as consistent inducement laws should be applied uniformly.

Can EU wean itself off essential drugs from China, India? DW 05/07/2024

Europe is vulnerable to China's influence by cutting off antibiotic supplies, and establishing a pharmaceutical database is crucial for securing medicinal products.
#generic drugs

Senators Call for Investigation of Health Insurers' Role in Driving Up Drug Costs

Senators call for investigation into high prices of generic drugs paid by health insurers
Investigation requested into role of shared ownership between health insurers and pharmacies
Senators Warren and Braun sent letter to U.S. Department of Health and Human Services

Opinion | Why We're Stuck in a Never-Ending Cycle of Drug Shortages

Drug shortages continue to impact millions of Americans, including cancer patients and those with treatable diseases.
Shortages have been a persistent problem since the early 2000s, lasting an average of 1.5 years and costing billions of dollars.

Senators Call for Investigation of Health Insurers' Role in Driving Up Drug Costs

Senators call for investigation into high prices of generic drugs paid by health insurers
Investigation requested into role of shared ownership between health insurers and pharmacies
Senators Warren and Braun sent letter to U.S. Department of Health and Human Services

Opinion | Why We're Stuck in a Never-Ending Cycle of Drug Shortages

Drug shortages continue to impact millions of Americans, including cancer patients and those with treatable diseases.
Shortages have been a persistent problem since the early 2000s, lasting an average of 1.5 years and costing billions of dollars.
moregeneric drugs
#novo-nordisk

Ozempic and Wegovy could soon be challenged by China's generic competitors

Intensifying competition in Chinese market for Novo Nordisk's diabetes drug Ozempic and weight loss treatment Wegovy.

Skinny jabs': weight-loss drugs set for new boom as generic versions emerge

The introduction of generic versions of weight-loss injectable drugs is expected to lead to increased uptake due to lower costs.

Ozempic and Wegovy could soon be challenged by China's generic competitors

Intensifying competition in Chinese market for Novo Nordisk's diabetes drug Ozempic and weight loss treatment Wegovy.

Skinny jabs': weight-loss drugs set for new boom as generic versions emerge

The introduction of generic versions of weight-loss injectable drugs is expected to lead to increased uptake due to lower costs.
morenovo-nordisk
[ Load more ]